Palliative trajectory markers for end-stage heart failure. Or "oh Toto. This doesn't look like kancerous!"

Mark Turris1, Chris Rauscher

  • 1Hospice Clinical Nurse Specialist, Vancouver Home Hospice Program, Vancouver Coastal Health, Vancouver Home Hospice Team, Vancouver, BC. mark_turris@vrhb.bc.ca

Insights

Identifying palliative care markers for heart failure patients is challenging due to symptom variability. This study reviewed literature and clinical data to find tools for accurately predicting a six-month prognosis for end-stage heart failure.

Area of Science:

  • Cardiology
  • Palliative Care Medicine

Background:

  • Heart failure presents significant morbidity and mortality, with Canadian annual mortality rates ranging from 25% to 40%.
  • End-stage heart failure patients experience severe, debilitating symptoms requiring effective palliative care.
  • Accurate prognostication for palliative care designation (six months or less) in heart failure is difficult due to unpredictable disease trajectories.

Purpose of the Study:

  • To review existing literature for clear palliative trajectory markers in heart failure.
  • To assess the feasibility of developing a tool to aid healthcare professionals in identifying patients with a prognosis of six months or less.

Main Methods:

  • A comprehensive review of current literature on heart failure palliative care markers.
  • Analysis of clinical experience within a major teaching hospital's cardiac clinic in Vancouver.

Main Results:

  • The study aimed to identify tangible markers for predicting a six-month or less trajectory in heart failure.
  • The research sought to determine if these markers could inform the development of a clinical decision-making tool.

Conclusions:

  • Clear palliative trajectory markers for heart failure are needed to improve prognostication.
  • A validated tool could significantly assist healthcare professionals in timely palliative care referrals for heart failure patients.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...